Introduction to biofilms in family medicine

Southern Medical Journal

Volumn 105, Issue 1, 2012, Pages 24-29

  Johnjulio, William ^a,b   Fuge, Ladonna H ^a,b   Kad, Manjusha ^a,b   Post, Christopher ^a,b  

^a ALLEGHENY HEALTH NETWORK   (United States)

^b ALLEGHENY GENERAL HOSPITAL   (United States)

Author keywords

biofilm; glycoprotein matrix; planktonic; quorum sensing; resistant

Indexed keywords

AZITHROMYCIN; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; GENTAMICIN; GRISEOFULVIN; KANAMYCIN; PIPERACILLIN; PSEUDOMONIC ACID; SPECTINOMYCIN; STREPTOMYCIN; TETRACYCLINE; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIAL GROWTH; BACTERIAL SINUSITIS; BACTERIAL VIABILITY; BACTERIOPLANKTON; BACTERIUM IDENTIFICATION; BIOFILM; CHRONIC RHINITIS; DIABETIC FOOT; FAMILY MEDICINE; GROWTH INHIBITION; HUMAN; INFECTION CONTROL; LIGHT; NONHUMAN; OTITIS MEDIA; QUORUM SENSING; REVIEW; URINARY TRACT INFECTION;

BACTERIAL INFECTIONS; BIOFILMS; FAMILY PRACTICE; HUMANS;

EID: 84855163886     PISSN: 00384348     EISSN: 15418243     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e31823c3ee4     Document Type: Review

References (43)

1. Chen L, Wen YM. The role of bacterial biofilm in persistent infections and control strategies. Int J Oral Sci 2011;3:66-73.
2. Lazar V, Chififiuc MC. Architecture and physiology of microbial bio-films. Roum Arch Microbiol Immunol 2010;69:95-107.
3. Fey PD. Modality of bacterial growth presents unique targets: how do we treat biofilm-mediated infections? Curr Opin Microbiol 2010;13: 610-615.
4. Weigel LM, Donlan RM, Shin DH, et al. High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm. Antimicrob Agents Chemother 2007;51:231-238. (Pubitemid 46047711)
5. Ceri H, Olson ME, Stremick C, et al. The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol 1999;37:1771-1776. (Pubitemid 29235221)
6. Keays T, Ferris W, Vandemheen KL, et al. A retrospective analysis of biofilm antibiotic susceptibility testing: a better predictor of clinical response in cystic fibrosis exacerbations. J Cyst Fibros 2009;8:122-127.
7. Pearlman AN, Conley DB. Review of current guidelines related to the diagnosis and treatment of rhinosinusitis. Curr Opin Otorhinolaryngol Head Neck Surg 2008;16:226-230. (Pubitemid 351677656)
8. Smith WM, Davidson TM, Murphy C. Regional variations in chronic rhinosinusitis, 2003-2006. Otorhinolaryngol Head Neck Surg 2009;141: 347-352.
9. Slavin RG. The upper and lower airways: the epidemiological and path-ophysiological connection. Allergy Asthma Proc 2008;29:553-556.
10. Dixon AE. Rhinosinusitis and asthma: the missing link. Curr Opin Pulm Med 2009;15:19-24.
11. Suh JD, Cohen NA, Palmer JN. Biofilms in chronic rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg 2010;18:27-31.
12. Prince AA, Steiger JD, Khalid AN, et al. Prevalence of biofilm-forming bacteria in chronic rhinosinusitis. Am J Rhinol 2008;22:239-245. (Pubitemid 351863570)
13. Foreman A, Psaltis AJ, Tan LW, et al. Characterization of bacterial and fungal biofilms in chronic rhinosinusitis. Am J Rhinol Allergy 2009;23: 556-561.
14. Foreman A, Singhal D, Psaltis AJ, et al. Targeted imaging modality selection for bacterial biofilms in chronic rhinosinusitis. Laryngoscope 2010;120:427-431.
15. Goldstein-Daruech N, Cope EK, Zhao KQ, et al. Tobacco smoke mediated induction of sinonasal microbial biofilms. PLoS One 2011;6:e15700.
16. Leibovitz E. Complicated otitis media and its implications. Vaccine 2008; 26(7 suppl):G16-G19.
17. Armbruster CE, Swords EW. Interspecies bacterial communication as a target for therapy in otitis media. Expert Rev Anti Infect Ther 2010;8: 1067-1070.
18. Leibovitz E, Greenberg D, Piglansky L, et al. Recurrent acute otitis media occurring within one month from completion of antibiotic therapy: relationship to the original pathogen. Pediatr Infect Dis J 2003;22:209-216.
19. Nistico L, Kreft R, Gieseke A, et al. An adenoid reservoir for pathogenic biofilm bacteria. J Clin Microbiol 2011;49:1411-1420.
20. Hoa M, Syamal M, Schaeffer MA, et al. Biofilms and chronic otitis media: an initial exploration into the role of biofilms in the pathogenesis of chronic otitis media. Am J Otolaryngol 2010;31:241-245.
21. Zuliani G, Carlisle M, Duberstein A, et al. Biofilm density in the pediatric nasopharynx: recurrent acute otitis media versus obstructive sleep apnea. Ann Otol Rhinol Laryngol 2009;118:519-524.
22. Moriyama S, Hotomi M, Shimada J, et al. Formation of biofilm by Haemophilus influenzae isolated from pediatric intractable otitis media. Auris Nasus Larynx 2009;36:525-531.
23. Campbell MK, Silver RW, Hoch JS, et al. Re-utilization outcomes and costs of minor acute illness treated at family physician offices, walk-in clinics, and emergency departments. Can Fam Physician 2005;51: 82-83.
24. Stickler DJ. Bacterial biofilms in patients with indwelling urinary catheters. Nat Clin Pract Urol 2008;5:598-608.
25. Trautner BW, Darouiche RO. Role of biofilm in catheter-associated urinary tract infection. Am J Infect Control 2004;32:177-183. (Pubitemid 38620840)
26. Falagas ME, Kapaskelis AM, Kouranos VD, et al. Outcome of antimicrobial therapy in documented biofilm-associated infections: a review of the available clinical evidence. Drugs 2009;69:1351-1361.
27. Holá V, Ruzicka F, Horka M. Microbial diversity in biofilm infections of the urinary tract with the use of sonication techniques. FEMS Immunol Med Microbiol 2010;59:525-528.
28. Macleod SM, Stickler DJ. Species interactions in mixed-community crystalline biofilms on urinary catheters. J Med Microbiol 2007;56: 1549-1557. (Pubitemid 350175083)
29. Jones BV, Mahenthiralingam E, Sabbuba NA, et al. Role of swarming in the formation of crystalline Proteus mirabilis biofilms on urinary catheters. J Med Microbiol 2005;54:807-813. (Pubitemid 41216275)
30. Ndip A, Jude EB. Emerging evidence for neuroischemic diabetic foot ulcers: model of care and how to adapt practice. Int J Low Extrem Wounds 2009;8:82-94.
31. James GA, Swogger E, Wolcott R, et al. Biofilms in chronic wounds. Wound Repair Regen 2008;16:37-44.
32. Fisher TK, Wolcott R, Wolk DM, et al. Diabetic foot infections: a need for innovative assessments. Int J Low Extrem Wounds 2010;9:31-36.
33. Dowd SE, Sun Y, Secor PR, et al. Survey of bacterial diversity in chronic wounds using Pyrosequencing, DGGE, and full ribosome shotgun sequencing. BMC Microbiol 2008;8:43.
34. Dowd SE, Wolcott RD, Sun Y, et al. Polymicrobial nature of chronic diabetic foot ulcer biofilm infections determined using bacterial tag encoded FLX amplicon pyrosequencing (bTEFAP). PLoS One 2008;3:e3326.
35. Ha KR, Psaltis AJ, Butcher AR, et al. In vitro activity of mupirocin on clinical isolates of Staphylococcus aureus and its potential implications in chronic rhinosinusitis. Laryngoscope 2008;118:535-540. (Pubitemid 351640625)
36. Uren B, Psaltis A, Wormald PJ. Nasal lavage with mupirocin for the treatment of surgically recalcitrant chronic rhinosinusitis. Laryngoscope 2008;118:1677-1680.
37. Zanin JC, Gon0alves RB, Junior AB, et al. Susceptibility of Streptococcus mutans biofilms to photodynamic therapy: an in vitro study. J Antimicrob Chemother 2005;56:324-330. (Pubitemid 41158520)
38. Bevilacqua IM, Nicolau RA, Khouri S, et al. The impact of photodynamic therapy on the viability of Streptococcus mutans in a planktonic culture. Photomed Laser Surg 2007;25:513-518.
39. Di Poto A, Sbarra MS, Provenza G, et al. The effect of photody-namic treatment combined with antibiotic action or host defense mechanisms on Staphylococcus aureus biofilms. Biomaterials 2009;30:158-166.
40. Fontana CR, Abernathy AD, Som S, et al. The antibacterial effect of photodynamic therapy in dental plaque-derived biofilms. J Periodontal Res 2009;44:751-759.
41. Vattem DA, Mihalik K, Crixell SH, et al. Dietary phytochemicals as quorum sensing inhibitors. Fitoerapia 2007;78:302-310. (Pubitemid 46777206)
42. Tateda K, Ishii Y, Kimura S, et al. Suppression of Pseudomonas aeru-ginosa quorum-sensing systems by macrolides: a promising strategy or an Oriental mystery? J Infect Chemother 2007;13:357-367. (Pubitemid 350308158)
43. Skindersoe M, Alhede M, Phipps R, et al. Effects of antibiotics on quorum sensing in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2008;52:3648-3663.